The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
A novel retinoblastoma therapy from genomic and epigenetic analyses
Open accessAbstract
Retinoblastoma is an aggressive childhood cancer of the developing retina that is initiated by the biallelic loss of RB1. Tumours progress very quickly following RB1 inactivation but the underlying mechanism is not known. Here we show that the retinoblastoma genome is stable, but that multiple cancer pathways can be epigenetically deregulated. To identify the mutations that cooperate with RB1 loss, we performed whole-genome sequencing of retinoblastomas. The overall mutational rate was very low; RB1 was the only known cancer gene mutated. We then evaluated the role of RB1 in genome stability and considered non-genetic mechanisms of cancer pathway deregulation. For example, the proto-oncogene SYK is upregulated in retinoblastoma and is required for tumour cell survival. Targeting SYK with a small-molecule inhibitor induced retinoblastoma tumour cell death in vitro and in vivo. Thus, retinoblastomas may develop quickly as a result of the epigenetic deregulation of key cancer pathways as a direct or indirect result of RB1 loss. The retinoblastoma genome is shown to be stable, but multiple cancer pathways are identified that are epigenetically deregulated, providing potential new therapeutic targets. Retinoblastoma is a rare and aggressive childhood cancer of the retina caused by loss of the RB1 gene. Whole-genome sequencing of four retinoblastomas now shows that the retinoblastoma genome is relatively stable, with a mutational rate among the lowest reported in human cancers and a remarkable lack of mutations in other tumour suppressor/oncogenic pathways. However, RB1 loss is associated with epigenetic deregulation of several cancer pathways. Significantly, the proto-oncogene SYK is upregulated in retinoblastoma and is required for tumour cell survival. A small-molecule inhibitor of SYK induced retinoblastoma tumour cell death in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948 · cited 1×
“When the RB1 gene was first cloned, it was found to undergo biallelic inactivation in virtually all retinoblastoma tumour”
BackgroundCancer-epigenetics comes of age
Jones, P. A., & Laird, P. W. (1999) · Nature Genetics · doi:10.1038/5947 · Cited by 2,344
The history of cancer epigenetics
Feinberg, A. P., & Tycko, B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1279 · Cited by 2,344
A mechanism linking extra centrosomes to chromosomal instability
Ganem, N. J., Godinho, S. A., & Pellman, D. (2009) · Nature · doi:10.1038/nature08136 · Cited by 1,422
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D., Dunford-Shore, B. H., McGrath, S., Hickenbotham, M., et al. (2008) · Nature · doi:10.1038/nature07485 · Cited by 1,422
Self-citationCovalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers
Chi, P., Allis, C. D., & Wang, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2876 · Cited by 1,099
Increased methylation variation in epigenetic domains across cancer types
Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Langmead, B., McDonald, O. G., Wen, B., Wu, H., Liu, Y., Diep, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.865 · Cited by 1,045
Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004) · Nature · doi:10.1038/nature02820 · Cited by 562
Benetti, R., Gonzalo, S., Jaco, I., Muñoz, P., Gonzalez, S., Schoeftner, S., Murchison, E., Andl, T., Chen, T., Klatt, P., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1399 · Cited by 435
Laird, P. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi113 · Cited by 398
An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis
Weinblatt, M. E., Kavanaugh, A., Genovese, M. C., Musser, T. K., Grossbard, E. B., & Magilavy, D. B. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000500 · Cited by 381
Chen, L., Monti, S., Juszczynski, P., Daley, J., Chen, W., Witzig, T. E., Habermann, T. M., Kutok, J. L., & Shipp, M. A. (2008) · Blood · doi:10.1182/blood-2007-07-100115 · Cited by 316
One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma
Corson, T. W., & Gallie, B. L. (2007) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20457 · Cited by 278 · cited 1×
“Tumour SJRB001 had four structural variations (two DEL and ins INS) including a gain of a region of chromosome 2 spanning MYCN ( Supplementary Table 12 ), and the only chromosomal lesion in SJRB002 was a gain of chromosome 6p, which occurs in about 40% of human retinoblastoma”
BackgroundLoss of pRB causes centromere dysfunction and chromosomal instability
Manning, A. L., Longworth, M. S., & Dyson, N. J. (2010) · Genes & Development · doi:10.1101/gad.1917310 · Cited by 240
Self-citationGobessi, S., Laurenti, L., Longo, P. G., Carsetti, L., Berno, V, Sica, S., Leone, G., & Efremov, D. G. (2009) · Leukemia · doi:10.1038/leu.2008.346 · Cited by 200
Buchner, M., Baer, C., Prinz, G., Dierks, C., Burger, M., Zenz, T., Stilgenbauer, S., Jumaa, H., Veelken, H., & Zirlik, K. (2010) · Blood · doi:10.1182/blood-2009-07-233692 · Cited by 176
Garrison, F. H. (1926) · Europe PMC (PubMed Central) · Cited by 167
Proteomic and Genetic Approaches Identify Syk as an AML Target
Hahn, C. K., Berchuck, J. E., Ross, K. N., Kakoza, R. M., Clauser, K., Schinzel, A. C., Ross, L., Galinsky, I., Davis, T. N., Silver, S. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.018 · Cited by 167
Suljagić, M., Longo, P. G., Bennardo, S., Perlas, E., Leone, G. G. M., Laurenti, L., & Efremov, D. G. (2010) · Blood · doi:10.1182/blood-2010-03-275180 · Cited by 164
Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas
Feldman, A. L., Sun, D. X., Law, M. E., Novak, A. J., Attygalle, A. D., Thorland, E. C., Fink, S. R., Vrana, J. A., Caron, B. L., Morice, W. G., et al. (2008) · Leukemia · doi:10.1038/leu.2008.77 · Cited by 160
Coexpression of Normally Incompatible Developmental Pathways in Retinoblastoma Genesis
McEvoy, J. D., Flores‐Otero, J., Zhang, J., Nemeth, K. M., Brennan, R. C., Bradley, C. L., Krafcik, F., Galindo, C. R., Wilson, M. W., Xiong, S., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.07.005 · Cited by 141
Self-citationA detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma
Squire, J. A., Gallie, B. L., & Phillips, R. A. (1985) · Human Genetics · doi:10.1007/bf00295364 · Cited by 128
Baudot, A. D., Jeandel, P. Y., Mouska, X., Maurer, U., Tartare‐Deckert, S., Raynaud, S., Cassuto, J. P., Ticchioni, M., & Deckert, M. (2009) · Oncogene · doi:10.1038/onc.2009.179 · Cited by 124
Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target
Young, R. M., Hardy, I. R., Clarke, R. L., Lundy, N., Pine, P. R., Turner, B. C., Potter, T. A., & Refaeli, Y. (2008) · Blood · doi:10.1182/blood-2008-05-158618 · Cited by 123
Benetti, R., Gonzalo, S., Jaco, I., Muñoz, P., González, S., Schoeftner, S., Murchison, E. P., Andl, T., Chen, T., Klatt, P., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0908-998b · Cited by 121
Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a
Brennan, R. C., Federico, S. M., Bradley, C. L., Zhang, J., Flores‐Otero, J., Wilson, M. W., Stewart, C. F., Zhu, F., Guy, K., & Dyer, M. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0058 · Cited by 102
Self-citationRB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts
Iovino, F., Lentini, L., Amato, A., & Di Leonardo, A. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-38 · Cited by 94
Wen, H., Andrejka, L., Ashton, J., Karess, R. E., & Lipsick, J. S. (2008) · Genes & Development · doi:10.1101/gad.1626308 · Cited by 85
Bourgo, R. J., Siddiqui, H., Fox, S. R., Solomon, D. A., Sansam, C. G., Yaniv, M., Muchardt, C., METZGER, D., Chambon, P., Roberts, C. W. M., et al. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1224 · Cited by 76
Lu, J., Ruhf, M.-L., Perrimon, N., & Leder, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610279104 · Cited by 73
Amato, A. M., Lentini, L., Schillaci, T., Iovino, F., & Leonardo, A. D. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-79 · Cited by 47
Yan, Y., Dunkel, I. J., Guan, X., Abramson, D. H., Jhanwar, S. C., & O'Reilly, R. J. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00277-4 · Cited by 8
Cited by
Adoptive immunotherapy for cancer: harnessing the T cell response
Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688
The landscape of genomic alterations across childhood cancers
ICGC PedBrain-Seq Project, Gröbner, S. N., ICGC MMML-Seq Project, Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., et al. (2018) · Nature · doi:10.1038/nature25480 · Cited by 1,572
Self-citationGermline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
Self-citationthe St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2014) · Nature Genetics · doi:10.1038/ng.2938 · Cited by 1,105
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Ma, X., Liu, Y., Liu, Y., Alexandrov, L. B., Edmonson, M. N., Gawad, C., Zhou, X., Li, Y., Rusch, M. C., Easton, J., et al. (2018) · Nature · doi:10.1038/nature25795 · Cited by 901
Self-citation
Metadata
- Authors
- Zhang, J., Benavente, C. A., McEvoy, J., Flores-Otero, J., Ding, L., Chen, X., Ulyanov, A., Wu, G., Wilson, M., Wang, J., Brennan, R., Rusch, M., Manning, A. L., Ma, J., Easton, J., Shurtleff, S., Mullighan, C., Pounds, S., Mukatira, S., Gupta, P., Neale, G., Zhao, D., Lu, C., Fulton, R. S., Fulton, L. L., Hong, X., Dooling, D. J., Ochoa, K., Naeve, C., Dyson, N. J., Mardis, E. R., Bahrami, A., Ellison, D., Wilson, R. K., Downing, J. R., & Dyer, M. A.
- Venue
- Nature
- Published
- 2012-01
- Volume
- 481
- Issue
- 7381
- Pages
- 329-334
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2142877023
- Cited by
- 516
- References
- 34
- FWCI
- 53.05
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.